22 min listen
PROTECT Data and Teplizumab in Newly Diagnosed T1D
FromDiabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives
PROTECT Data and Teplizumab in Newly Diagnosed T1D
FromDiabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives
ratings:
Length:
15 minutes
Released:
Oct 25, 2023
Format:
Podcast episode
Description
In this episode, hosts discuss data from the PROTECT trial, which examined the effects of teplizumab on beta-cell function in patients with newly diagnosed type 1 diabetes.
Released:
Oct 25, 2023
Format:
Podcast episode
Titles in the series (94)
Diabetes Research & COVID-19 by Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives